3-Morpholinecarboxamide - CAS 848488-74-4
Catalog: |
BB058946 |
Product Name: |
3-Morpholinecarboxamide |
CAS: |
848488-74-4 |
Synonyms: |
morpholine-3-carboxamide; 3-Morpholinecarboxamide; Morpholine-3-carboxylic acid amide |
IUPAC Name: | morpholine-3-carboxamide |
Description: | 3-Morpholinecarboxamide is derived from 3-Morpholinecarbonitrile (M723800), which is used as a reactant in the synthesis of N-methyl pyrimidone derivatives as potent and orally bioavailable HIV integrase inhibitors. |
Molecular Weight: | 130.15 |
Molecular Formula: | C5H10N2O2 |
Canonical SMILES: | C1COCC(N1)C(=O)N |
InChI: | InChI=1S/C5H10N2O2/c6-5(8)4-3-9-2-1-7-4/h4,7H,1-3H2,(H2,6,8) |
InChI Key: | YPSPPJRTCRMQGD-UHFFFAOYSA-N |
References: | Gardelli, C., et. al. J. Med. Chem., 50, 4953 (2007). |
GHS Hazard Statement: | H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation] |
Precautionary Statement: | P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P354+P338, P317, P319, P321, P332+P317, P362+P364, P403+P233, P405, and P501 |
Signal Word: | Danger |
Publication Number | Title | Priority Date |
WO-2021212039-A1 | Inhibitors of cysteine proteases and methods of use thereof | 20200417 |
TW-202134230-A | Substituted aminoquinolones as dgkalpha inhibitors for immune activation | 20191128 |
WO-2021016102-A1 | Inhibitors of tyrosine kinase | 20190719 |
TW-202110819-A | Substituted 1-oxo-isoindoline-5-carboxamide compounds, compositions thereof, and methods of treatment therewith | 20190531 |
TW-202102482-A | Cystic fibrosis transmembrane conductance regulator modulating agents | 20190403 |
WO-2020151232-A1 | 1,2,3,4-tetrahydroquinoxaline derivative, preparation method therefor and application thereof | 20190123 |
WO-2020151232-A9 | 1,2,3,4-tetrahydroquinoxaline derivative, preparation method therefor and application thereof | 20190123 |
WO-2020025517-A1 | Tlr7/8 antagonists and uses thereof | 20180731 |
AU-2019313441-A1 | TLR7/8 antagonists and uses thereof | 20180731 |
CA-3108099-A1 | Tlr7/8 antagonists and uses thereof | 20180731 |
Complexity: | 116 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 130.074227566 |
Formal Charge: | 0 |
Heavy Atom Count: | 9 |
Hydrogen Bond Acceptor Count: | 3 |
Hydrogen Bond Donor Count: | 2 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 130.074227566 |
Rotatable Bond Count: | 1 |
Topological Polar Surface Area: | 64.4Ų |
Undefined Atom Stereocenter Count: | 1 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | -1.6 |
-
Catalog: BB069928
((2S,4R)-2-(Chloromethyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methyl 4-Methylbenzenesulfonate
Detail
-
Catalog: BB069926
((2R,4R)-2-(Chloromethyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methyl 4-Methylbenzenesulfonate
Detail
-
Catalog: BB075348
((2S,3S,4R,5R)-5-(4-Amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl dihydrogen phosphate, sodium salt
Detail
-
Catalog: BB061033
((2R,5S,10aS,10bS)-10b-Hydroxy-5-isopropyl-2-methyl-3,6-dioxooctahydro-2H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl)carbamic Acid Benzyl Ester
Detail
-
Catalog: BB069924
((2S,4S)-2-(Chloromethyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methyl 4-Methylbenzenesulfonate
Detail
-
Catalog: BB069173
((1-Chloro-2-methylpropan-2-yl)oxy)trimethylsilane
Detail
-
Catalog: BB055105
((2R,5S,10aS,10bS)-5-Benzyl-8,10b-bis(benzyloxy)-2-methyl-3,6-dioxooctahydro-2H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl)carbamic Acid Benzyl Ester
Detail
-
Catalog: BB072640
((2R,3S,4R,5R)-5-(4-(Benzyloxy)-2-oxopyridin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl bis(2-cyanoethyl) Phosphate
Detail
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Other Building Blocks
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS